Geode Capital Management
AGIO icon

Geode Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Geode Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58.4M Buy
1,574,268
+106,358
+7% +$3.23M ﹤0.01% 1543
2026
Q1 		$49.7M Buy
1,467,910
+54,372
+4% +$1.54M ﹤0.01% 1497
2025
Q4 		$38.5M Sell
1,413,538
-2,777
-0.2% -$97.4K ﹤0.01% 1645
2025
Q3 		$56.9M Buy
1,416,315
+10,560
+0.8% +$397K ﹤0.01% 1393
2025
Q2 		$46.8M Buy
1,405,755
+11,174
+0.8% +$339K ﹤0.01% 1460
2025
Q1 		$40.9M Buy
1,394,581
+44,930
+3% +$1.49M ﹤0.01% 1500
2024
Q4 		$44.4M Sell
1,349,651
-7,880
-0.6% -$370K ﹤0.01% 1502
2024
Q3 		$60.3M Buy
1,357,531
+6,101
+0.5% +$277K ﹤0.01% 1307
2024
Q2 		$58.3M Buy
1,351,430
+68,515
+5% +$2.47M 0.01% 1255
2024
Q1 		$37.5M Buy
1,282,915
+28,638
+2% +$767K ﹤0.01% 1550
2023
Q4 		$27.9M Buy
1,254,277
+55,317
+5% +$1.24M ﹤0.01% 1715
2023
Q3 		$29.7M Buy
1,198,960
+41,293
+4% +$1.09M ﹤0.01% 1563
2023
Q2 		$32.8M Buy
1,157,667
+68,308
+6% +$1.7M ﹤0.01% 1525
2023
Q1 		$25M Buy
1,089,359
+33,801
+3% +$898K ﹤0.01% 1649
2022
Q4 		$29.6M Buy
1,055,558
+28,576
+3% +$805K ﹤0.01% 1507
2022
Q3 		$29M Sell
1,026,982
-97,022
-9% -$2.6M ﹤0.01% 1475
2022
Q2 		$24.9M Buy
1,124,004
+106,324
+10% +$2.4M ﹤0.01% 1605
2022
Q1 		$29.6M Sell
1,017,680
-26,336
-3% -$805K ﹤0.01% 1615
2021
Q4 		$34.3M Sell
1,044,016
-3,726
-0.4% -$150K ﹤0.01% 1587
2021
Q3 		$48.4M Sell
1,047,742
-1,108
-0.1% -$53.5K 0.01% 1307
2021
Q2 		$57.8M Buy
1,048,850
+294,468
+39% +$16.5M 0.01% 1184
2021
Q1 		$39M Buy
754,382
+29,151
+4% +$1.44M 0.01% 1428
2020
Q4 		$31.4M Buy
725,231
+18,204
+3% +$720K 0.01% 1428
2020
Q3 		$24.7M Sell
707,027
-28,626
-4% -$1.25M ﹤0.01% 1377
2020
Q2 		$39.3M Buy
735,653
+10,468
+1% +$485K 0.01% 1026
2020
Q1 		$25.7M Buy
725,185
+42,314
+6% +$1.96M 0.01% 1132
2019
Q4 		$32.6M Buy
682,871
+95,823
+16% +$3.62M 0.01% 1226
2019
Q3 		$19M Buy
587,048
+7,091
+1% +$294K ﹤0.01% 1524
2019
Q2 		$28.9M Buy
579,957
+42,922
+8% +$2.29M 0.01% 1227
2019
Q1 		$36.2M Sell
537,035
-9,533
-2% -$555K 0.01% 1023
2018
Q4 		$25.2M Buy
546,568
+69,603
+15% +$4.3M 0.01% 1120
2018
Q3 		$36.8M Buy
476,965
+4,606
+1% +$371K 0.01% 991
2018
Q2 		$39.8M Buy
472,359
+48,758
+12% +$4.25M 0.01% 889
2018
Q1 		$34.6M Buy
423,601
+54,089
+15% +$4.18M 0.01% 917
2017
Q4 		$21.1M Buy
369,512
+4,073
+1% +$256K 0.01% 1236
2017
Q3 		$24.4M Buy
365,439
+19,050
+5% +$1.14M 0.01% 1092
2017
Q2 		$17.8M Buy
346,389
+82,490
+31% +$4.22M 0.01% 1271
2017
Q1 		$15.4M Buy
263,899
+20,336
+8% +$975K 0.01% 1346
2016
Q4 		$10.2M Buy
243,563
+24,061
+11% +$1.26M ﹤0.01% 1562
2016
Q3 		$11.6M Buy
219,502
+34,732
+19% +$1.51M 0.01% 1395
2016
Q2 		$7.74M Buy
184,770
+7,901
+4% +$390K ﹤0.01% 1626
2016
Q1 		$7.18K Buy
176,869
+4,325
+3% +$185K ﹤0.01% 1609
2015
Q4 		$11.2M Buy
172,544
+8,910
+5% +$584K 0.01% 1301
2015
Q3 		$11.6M Buy
163,634
+84,724
+107% +$8.28M 0.01% 1246
2015
Q2 		$8.77M Buy
78,910
+409
+0.5% +$44.1K 0.01% 1501
2015
Q1 		$7.4M Buy
78,501
+7,999
+11% +$896K ﹤0.01% 1604
2014
Q4 		$7.9M Buy
70,502
+9,102
+15% +$813K ﹤0.01% 1524
2014
Q3 		$3.77M Buy
61,400
+2,057
+3% +$88.7K ﹤0.01% 1941
2014
Q2 		$2.72M Buy
59,343
+20,614
+53% +$840K ﹤0.01% 2193
2014
Q1 		$1.52M Buy
38,729
+343
+0.9% +$11.5K ﹤0.01% 2515
2013
Q4 		$919K Buy
38,386
+558
+1% +$12.7K ﹤0.01% 2766
2013
Q3 		$1.06M Buy
+37,828
New +$1.04M ﹤0.01% 2558

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Geode Capital Management's AGIO Position: Q2 2026 in Review

Geode Capital Management increased its Agios Pharmaceuticals (AGIO) stake by 7.2% in Q2 2026, buying an estimated $3.23M and bringing the position to 1,574,268 shares worth $58.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1543.

Geode Capital Management first reported a position in AGIO in Q3 2013 and has held it in 52 quarters since. The position peaked at $60.3M in Q3 2024. 236 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Geode Capital Management held 1,574,268 shares of Agios Pharmaceuticals worth $58.4M as of Q2 2026.
  • Geode Capital Management bought 106,358 Agios Pharmaceuticals shares in Q2 2026, an estimated $3.23M.
  • Agios Pharmaceuticals made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #1543 holding.
  • Geode Capital Management first reported a position in Agios Pharmaceuticals in Q3 2013 and has held it in 52 quarters since.
  • Geode Capital Management's Agios Pharmaceuticals position peaked at $60.3M in Q3 2024.
  • 236 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.